Man Group’s GeneDx Holdings WGS Stock Holding History

Man Group’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-8,102	Closed	-$520K	–	2644
2026 Q1	$520K	Buy	+8,102	New	+$739K	﹤0.01%	2072
2022 Q2	–	Sell	-2,739	Closed	-$278K	–	2437
2022 Q1	$278K	Sell	2,739 -31	-1%	-$3.45K	﹤0.01%	1795
2021 Q4	$408K	Buy	+2,770	New	+$619K	﹤0.01%	1592

Other funds holding WGS

Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Man Group's WGS Position: Q2 2026 in Review

Man Group sold out of GeneDx Holdings (WGS) in Q2 2026, closing a stake of 8,102 shares — an estimated $520K sold.

Man Group first reported a position in WGS in Q4 2021 and held it in 3 quarters. The position peaked at $520K in Q1 2026. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

Man Group reported no remaining GeneDx Holdings position as of Q2 2026 after selling out during the quarter.
Man Group sold 8,102 GeneDx Holdings shares in Q2 2026, an estimated $520K.
Man Group first reported a position in GeneDx Holdings in Q4 2021 and held it in 3 quarters.
Man Group's GeneDx Holdings position peaked at $520K in Q1 2026.
223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.